ISOMORPHIC LABS
LIVE

Serial Number

79440662

Owner

Isomorphic Labs Limited

Attorney

Cynthia Walden

Filing Date

Sep 22, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ISOMORPHIC LABS Trademark

Serial Number: 79440662

ISOMORPHIC LABS is a trademark filed by Isomorphic Labs Limited on September 22, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Isomorphic Labs Limited (12 trademarks)

280 Bishopsgate
London EC2M4RB , GB

Entity Type: 99

Trademark Details

Filing Date

September 22, 2025

Registration Date

Not Registered

Goods & Services

Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service [saas] services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

Pharmaceutical preparations.

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development.

Filing History

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 1, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 1, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 1, 2026 COAR
REFUSAL PROCESSED BY IB
Mar 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 5, 2026 RFCS
REFUSAL PROCESSED BY MPU
Mar 5, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 4, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 3, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 29, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 7, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 1, 2026 REPR